Quest Laboratories Ltd Share Price

137.5
(-1.47%)
Jul 23, 2024|03:32:43 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open140
  • Day's High140
  • 52 Wk High196.8
  • Prev. Close139.55
  • Day's Low135.8
  • 52 Wk Low102
  • Turnover (lac)49.5
  • P/E22.65
  • Face Value10
  • Book Value48.29
  • EPS6.16
  • Mkt. Cap (Cr.)225.32
  • Div. Yield0
No Records Found

Quest Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

140

Prev. Close

139.55

Turnover(Lac.)

49.5

Day's High

140

Day's Low

135.8

52 Week's High

196.8

52 Week's Low

102

Book Value

48.29

Face Value

10

Mkt Cap (₹ Cr.)

225.32

P/E

22.65

EPS

6.16

Divi. Yield

0

Quest Laboratories Ltd Corporate Action

29 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Quest Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Quest Laboratories Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:43 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 90.36%

Foreign: 0.00%

Indian: 90.36%

Non-Promoter- 9.63%

Institutions: 9.63%

Non-Institutions: 0.00%

Custodian: 0.00%

Share Price

Quest Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021

Equity Capital

1.08

1.08

1.08

Preference Capital

0

0

0

Reserves

13.94

8.92

4.81

Net Worth

15.02

10

5.89

Minority Interest

View Balance Sheet
Loading...

No Record found

View Profit & Loss
Loading...

No Record found

View Cash Flow
Loading...

No Record found

View Ratios

No Record found

Quest Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.35

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.8

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,490

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.55

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,770.9

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Quest Laboratories Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Mr Anil Kumar Sabarwal

Whole-time Director

Ms Tejaswini Sabarwal

Whole-time Director

Rahul Dangi

Independent Director

Mr. Gautam Chand Kothari

Independent Director

Amit Ramesh Chandak

Independent Director

Basant Lai Menghwani

Company Sec. & Compli. Officer

Jayesh Jain

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Quest Laboratories Ltd was originally incorporated under the name Quest Laboratories Private Limited vide Certificate of Incorporation dated June 01, 1998, issued by the Registrar of Companies Madhya Pradesh, Gwalior. Thereafter, the status of the Company changed to Public Limited and the name of Company was changed to Quest Laboratories Limited vide fresh Certificate of Incorporation issued on January 23, 2024, by Registrar of Companies, Centralised Processing Centre.The Company is engaged in manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark Quest Laboratories Limited. The company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.The Company holds WHO Schedule M GMP, and GLP certifications, adhering to the stringent guidelines set by the World Health Organization. It also possesses Good Laboratory Practice (GLP) certificate issued by Food & Drug Administration, Bhopal, Madhya Pradesh, indicating its commitment to maintaining high standards of quality and compliance in laboratory operations, particularly within the pharmaceutical sector.The Company has a
Read More

Company FAQs

What is the Quest Laboratories Ltd share price today?

Down Arrow

The Quest Laboratories Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹137.5 today.

What is the Market Cap of Quest Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Quest Laboratories Ltd is ₹225.32 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Quest Laboratories Ltd?

Down Arrow

The PE and PB ratios of Quest Laboratories Ltd is 22.65 and 3.18 as of 23 Jul ‘24

What is the 52 Week High and Low of Quest Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Quest Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Quest Laboratories Ltd is ₹102 and ₹196.8 as of 23 Jul ‘24

What is the CAGR of Quest Laboratories Ltd?

Down Arrow

Quest Laboratories Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at -5.29% and 1 Month at -11.20%.

What is the shareholding pattern of Quest Laboratories Ltd?

Down Arrow

The shareholding pattern of Quest Laboratories Ltd is as follows:
Promoters - 65.83 %
Institutions - 11.70 %
Public - 22.47 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.